Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders. | Cancers (Basel) | 2022 | 35626087 | PubTator, text mining | PubMed |
| Latest Contributions of Genomics to T-Cell Acute Lymphoblastic Leukemia (T-ALL). | Cancers (Basel) | 2022 | 35626077 | PubTator, text mining | PubMed |
| Dysregulation and therapeutic targeting of RNA splicing in cancer. | Nat Cancer | 2022 | 35624337 | PubTator, text mining | PubMed |
| De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences. | Mediterr J Hematol Infect Dis | 2022 | 35615324 | PubTator, text mining | PubMed |
| Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia. | Commun Med (Lond) | 2022 | 35603299 | PubTator, text mining | PubMed |
| Educational Case: Metastatic endometrial stromal sarcoma presenting as bone pain: a diagnostic approach to uterine mesenchymal tumors. | Acad Pathol | 2022 | 35600747 | PubTator, text mining | PubMed |
| Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report. | Brain Tumor Pathol | 2022 | 35596897 | PubTator, text mining | PubMed |
A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer. | Front Med (Lausanne) | 2022 | 35592856 | PubTator, text mining | PubMed |
| Somatic mutations in SF3B1 aberrant-negative MDS-RS most commonly involved in TP53 genes. | J Cell Mol Med | 2022 | 35582925 | PubTator, text mining | PubMed |
| Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533. | J Clin Oncol | 2022 | 35580298 | PubTator, text mining | PubMed |
| Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma. | Am J Surg Pathol | 2022 | 35575789 | PubTator, text mining | PubMed |
| Sonic Hedgehog Signaling in Cerebellar Development and Cancer. | Front Cell Dev Biol | 2022 | 35573667 | PubTator, text mining | PubMed |
| EML4-NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review. | Front Med (Lausanne) | 2022 | 35572973 | PubTator, text mining | PubMed |
| BCOR-CCNB3 sarcoma with concurrent RNF213-SLC26A11 gene fusion: a rare sarcoma with altered histopathological features after chemotherapy. | World J Surg Oncol | 2022 | 35568949 | PubTator, text mining | PubMed |
| RB1-Negative Retinal Organoids Display Proliferation of Cone Photoreceptors and Loss of Retinal Differentiation. | Cancers (Basel) | 2022 | 35565295 | PubTator, text mining | PubMed |
| Malignant Superficial Mesenchymal Tumors in Children. | Cancers (Basel) | 2022 | 35565289 | PubTator, text mining | PubMed |
| Embryonal tumors in the WHO CNS5 classification: A Review. | Indian J Pathol Microbiol | 2022 | 35562137 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors. | Sci Adv | 2022 | 35559673 | PubTator, text mining | PubMed |
| The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes. | Front Oncol | 2022 | 35558519 | PubTator, text mining | PubMed |
| X-linked genes exhibit miR6891-5p-regulated skewing in Sjögren's syndrome. | J Mol Med (Berl) | 2022 | 35538149 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=55